Press release dated September 23, 2026, titled "Glenmark Pharmaceuticals receives Establishment Inspection Report (EIR) from U.S. FDA for its Goa facility with VAI classification".
News & Filings
NSE filings · newest first · 2 on recordWed, 23 Sept, 2026
Mon, 21 Sept, 2026
Schedule of meet
Source: NSE corporate announcements, as filed by the company. Times are IST. Press coverage is not included yet.
Filing activity · 30 days
2filings · +2 vs the 30 days before
● Investor meets 1● Press & deals 1
NSE filings by type. Press coverage and sentiment are not included yet.
Material vs routine · 90 days
Material events 1 in 90 days
23 SeptPress release Press release dated September 23, 2026, titled "Glenmark Pharmaceuticals receives Establishment Inspection Report (EIR) from U.S. FDA for its Goa facility with VAI classification". PDF
Routine disclosures 1
investor meets 1
Split by NSE filing category: business events (results, ratings, deals, leadership, capital actions, regulatory) versus schedules, notices and general updates. Not a view on importance.
Corporate Actions
loading…